Talk:FOLFIRI

Medicine Low‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Low	This article has been rated as Low-importance on the project's importance scale.
	Information from this article appears on Portal:Medicine in the Did you know section.

Text and/or other creative content from this version of FOLFIRI was copied or moved into FOLFIRINOX with this edit. The former page's history now serves to provide attribution for that content in the latter page, and it must not be deleted as long as the latter page exists.

News

FDA Grants New Indication for Cyramza for Metastatic Colorectal Cancer could be mentioned - eg can now have ramucirumab added. Says the FOLFIRI-only arm had PFS of 4.5 months, and median overall survival of 11.7 months. - Rod57 (talk) 08:10, 13 May 2015 (UTC)[reply]

Needs a History section

How and when was it developed ? How widely used is it ? eg in USA, Canada, EU, Australia ? - Rod57 (talk) 08:18, 13 May 2015 (UTC)[reply]